0001606074-19-000002.txt : 20190508 0001606074-19-000002.hdr.sgml : 20190508 20190508163638 ACCESSION NUMBER: 0001606074-19-000002 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190508 DATE AS OF CHANGE: 20190508 EFFECTIVENESS DATE: 20190508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Svennilson Peter CENTRAL INDEX KEY: 0001606074 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16412 FILM NUMBER: 19807198 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001606074 XXXXXXXX 03-31-2019 03-31-2019 Svennilson Peter

1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158

13F HOLDINGS REPORT 028-16412 N Peter Svennilson (415) 865-2050 /s/ Peter Svennilson San Francisco CA 05-08-2019 3 9 187742 false 1 0001600420 028-19198 COLUMN GROUP II, LP 2 0001645333 028-19199 Column Group II GP, LP 3 0001182464 028-16413 GOEDDEL DAVID V INFORMATION TABLE 2 Info_Table.xml Arcus Biosciences Inc. COM 03969F109 38350 3070423 SH OTR 1, 2, 3 0 3070423 0 Arcus Biosciences Inc. COM 03969F109 5876 470427 SH OTR 3 0 470427 0 Constellation Pharmceticls I COM 210373106 34618 2554850 SH OTR 3 0 2554850 0 Constellation Pharmceticls I COM 210373106 16460 1214742 SH OTR 3 0 1214742 0 Constellation Pharmceticls I COM 210373106 12308 908347 SH OTR 3 0 908347 0 Gritstone Oncology Inc. COM 39868T105 41269 3102934 SH OTR 1, 2, 3 0 3102934 0 Immune Design Corp. COM 45252L103 4680 800000 SH OTR 1, 2, 3 0 800000 0 Immune Design Corp. COM 45252L103 18497 3161942 SH OTR 3 0 3161942 0 Immune Design Corp. COM 45252L103 15684 2681000 SH OTR 3 0 2681000 0